BioNTech Manufacturing Marburg GmbH
BioNTech Manufacturing Marburg GmbH has been represented at the site since November 2020. The production site is currently being expanded for the production of mRNA vaccines.
BioNTech is a German biotechnology company dedicated to the development and production of active immunotherapies for a patient-specific approach to the treatment of serious diseases. Marburg has a long and successful history as a centre for vaccine manufacturing. Over the last five years, the Marburg site has focused on a portfolio that includes the production of recombinant proteins and cell-gene therapies.